AGER and obesity due to melanocortin 4 receptor deficiency: Decreased levels of circulating sRAGE or esRAGE have been reported in patients with hypertension [33], metabolic syndrome (MS) [34], in the early phase of type 2 diabetes [35,36] and obesity suggesting sRAGE as an early predictor of cardiovascular risk.